As of 2026-03-30, the Relative Valuation of Cullinan Oncology Inc (CGEM) is (78.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.85 USD, the upside of Cullinan Oncology Inc based on Relative Valuation is -707.1%.
The range of the Relative Valuation is (72.58) - (83.19) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.1x - 25.1x | 22.0x |
| Forward P/E multiples | 20.0x - 22.9x | 21.0x |
| Fair Price | (72.58) - (83.19) | (78.01) |
| Upside | -664.8% - -747.4% | -707.1% |
| Date | P/E |
| 2026-03-25 | -3.87 |
| 2026-03-24 | -3.75 |
| 2026-03-23 | -3.53 |
| 2026-03-20 | -3.51 |
| 2026-03-19 | -3.60 |
| 2026-03-18 | -3.61 |
| 2026-03-17 | -3.70 |
| 2026-03-16 | -3.86 |
| 2026-03-13 | -3.71 |
| 2026-03-12 | -3.84 |
| 2026-03-11 | -3.94 |
| 2026-03-10 | -4.10 |
| 2026-03-09 | -4.21 |
| 2026-03-06 | -4.33 |
| 2026-03-05 | -4.29 |
| 2026-03-04 | -4.49 |
| 2026-03-03 | -4.33 |
| 2026-03-02 | -4.40 |
| 2026-02-27 | -4.27 |
| 2026-02-26 | -4.19 |
| 2026-02-25 | -3.95 |
| 2026-02-24 | -3.93 |
| 2026-02-23 | -3.85 |
| 2026-02-20 | -3.76 |
| 2026-02-19 | -3.82 |
| 2026-02-18 | -3.42 |
| 2026-02-17 | -3.36 |
| 2026-02-13 | -3.19 |
| 2026-02-12 | -3.22 |
| 2026-02-11 | -3.29 |
| 2026-02-10 | -3.36 |
| 2026-02-09 | -3.26 |
| 2026-02-06 | -3.37 |
| 2026-02-05 | -3.26 |
| 2026-02-04 | -3.39 |
| 2026-02-03 | -3.64 |
| 2026-02-02 | -3.50 |
| 2026-01-30 | -3.29 |
| 2026-01-29 | -3.28 |
| 2026-01-28 | -3.26 |
| 2026-01-27 | -3.40 |
| 2026-01-26 | -3.30 |
| 2026-01-23 | -3.44 |
| 2026-01-22 | -3.46 |
| 2026-01-21 | -3.19 |
| 2026-01-20 | -2.99 |
| 2026-01-16 | -2.95 |
| 2026-01-15 | -2.93 |
| 2026-01-14 | -2.99 |
| 2026-01-13 | -2.95 |